
BioPro: An oncology-focused biopharmaceutical firm, expert in marketing licensed products across Asia.
BioPro Pharmaceutical is an oncology-focused biopharmaceutical company with a mission to provide innovative cancer treatments across Asia. The company specializes in marketing in-licensed pharmaceutical products in China and other Asian/Pacific countries, leveraging its regulatory expertise and marketing know-how. BioPro targets a pharmaceutical market worth US$30 billion, aiming to improve patient outcomes through advanced oncology solutions.
BioPro has established a robust infrastructure in major Asian markets, demonstrating significant impact in the region's healthcare landscape. The company's strategic approach has enabled it to effectively navigate regulatory environments and deliver vital oncology treatments. BioPro's efforts have contributed to enhanced access to cutting-edge cancer therapies, solidifying its reputation as a leader in the Asian biopharmaceutical sector.

Betta Pharmaceuticals Co.
bettapharma.com

BioRay Pharmaceuticals

ACT Biotech

Biozone Pharmaceuticals

Sinogen Biopharma

Sino Biopharmaceutical

Kyntra Bio
fibrogen.com

MediProPharma

Peak Bio
peak-bio.com

BioNumerik Pharmaceuticals

Abvc Biopharma

BeOne Medicines
beigene.com

Boston Biopharma

Provenance Biopharmaceuticals
provenancebio.com

China PharmaHub
Companies similar to BioPro Pharmaceutical include Betta Pharmaceuticals Co., BioRay Pharmaceuticals, ACT Biotech and Biozone Pharmaceuticals.
BioPro Pharmaceutical was founded in 2003.
BioPro Pharmaceutical's headquarters is located in San Francisco, CA, US.
BioPro Pharmaceutical's most recent funding round was for $5M (USD) in October 2005.
As of Oct 18, 2005, BioPro Pharmaceutical has raised a total of $5M (USD).
BioPro Pharmaceutical has 7 employees as of Feb 5, 2024.